Subscribe to RSS

DOI: 10.1590/0004-282X20180038
Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
Análise longitudinal da memória episódica verbal em pacientes com esclerose múltipla remitente-recorrente
ABSTRACT
Objective: A 4.5-year follow-up study was conducted to characterize baseline verbal episodic memory (VEM) and its behavior and to assess the effects of relapsing-remitting multiple sclerosis (RRMS) on this domain.
Methods: Twenty-nine patients with RRMS underwent two neuropsychological assessments performed an average of 4.5 years apart. Twenty-six control participants underwent a single neuropsychological assessment. A significance level of p < 0.005 was adopted to denote a significant difference between the groups on the Mann Whitney and Wilcoxon paired statistical analyses.
Results: No statistical difference was found in the results of the VEM tests between the first and second neuropsychological assessments of the patients. However, a statistical difference was evident between the patient and control groups in the results of the VEM tests.
Conclusion: The patient group showed changes in the VEM relative to the control group. After approximately 4.5 years of disease, the patient performance on the VEM stabilized or improved.
RESUMO
Objetivo: Neste estudo, propomos a caracterização da Memória Episódica Verbal (MEV) basal e o seu comportamento após o período de 4,5 anos de doença, a fim de avaliar o efeito da EMRR neste domínio.
Métodos: Vinte e nove pacientes com EMRR foram submetidos a duas avaliações neuropsicológicas realizadas entre um intervalo de tempo médio de 4,5 anos. Vinte e seis controles foram submetidos à avaliação neuropsicológica única. Considerou-se nível de significância p <0,005 para delinear diferença significante entre os grupos nas análises estatísticas Mann Whitney e Wilcoxon pareado.
Resultados: Não houve diferença estatística nos resultados dos testes de MEV entre a primeira e segunda avaliação neuropsicológica realizada pelos pacientes. Houve discrepância estatística nos resultados dos testes de MEV entre o grupo dos pacientes e controles.
Conclusão: O grupo de pacientes apresentou alterações de MEV quando comparado aos controles. Após 4,5 anos aproximadamente os pacientes estabilizaram ou melhoraram seu desempenho em MEV.
Publication History
Received: 02 August 2017
Accepted: 22 February 2018
Article published online:
25 August 2023
© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008 Dec;7(12):1139-51. https://doi.org/10.1016/S1474-4422(08)70259-X
- 2 Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med. 2012 Apr;103(2):73-96.
- 3 Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006 Jun;245(1-2):41-6. https://doi.org/10.1016/j.jns.2005.08.019
- 4 Moccia M, Lanzillo R, Palladino R, Chang KC, Costabile T, Russo C et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler. 2016 Apr;22(5):659-67. https://doi.org/10.1177/1352458515599075
- 5 Brissart H, Morele E, Baumann C, Debouverie M. Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both? Neurol Sci. 2012 Oct;33(5):1117-23. https://doi.org/10.1007/s10072-011-0915-7
- 6 Strober LB, Rao SM, Lee JC, Fischer E, Rudick R. Cognitive impairment in multiple sclerosis: An 18 year follow-up study. Mult Scler Relat Disord. 2014 Jul;3(4):473-81. https://doi.org/10.1016/j.msard.2014.03.004
- 7 Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. https://doi.org/10.1002/ana.22366
- 8 Ringe WK, Saine KC, Lacritz LH, Hynan LS, Cullum CM. Dyadic short forms of the Wechsler Adult Intelligence Scale-III. Assessment. 2002 Sep;9(3):254-60. https://doi.org/10.1177/1073191102009003004
- 9 Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. [Suggestions for utilization of the mini-mental state examination in Brazil]. Arq Neuropsiquiatr. 2003 Sep;61(3B):777-81. Portuguese. https://doi.org/10.1590/S0004-282X2003000500014
- 10 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
- 11 Brandt JB, Benedict RH. Hopkins verbal learning test-revised: professional manual. Lutz: Psychological Assessment Resource; 2001.
- 12 Wechsler D. Wechsler Memory Scale. (WMS-III). 3rd ed. New York: The Psychological Corporation; 1999.
- 13 Gorenstein C, Wang YP, Argimon IL, Werlang BS. Manual do inventário de depressão de Beck - BDI-II. São Paulo: Casa do Psicólogo; 2011.
- 14 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52. https://doi.org/10.1212/WNL.33.11.1444
- 15 Fuso SF, Callegaro D, Pompéia S, Bueno OF. Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits. Arq Neuropsiquiatr. 2010 Apr;68(2):205-11. https://doi.org/10.1590/S0004-282X2010000200010
- 16 Faglioni P, Bertolani L, Botti C, Merelli E. Verbal learning strategies in patients with multiple sclerosis. Cortex. 2000 Apr;36(2):243-63. https://doi.org/10.1016/S0010-9452(08)70527-6
- 17 Bergendal G, Fredrikson S, Almkvist O. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Eur Neurol. 2007;57(4):193-202. https://doi.org/10.1159/000099158
- 18 Jønsson A, Andresen J, Storr L, Tscherning T, Soelberg Sørensen P, Ravnborg M. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci. 2006 Jun;245(1-2):77-85. https://doi.org/10.1016/j.jns.2005.09.016
- 19 Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP; Copaxone Study Group. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci. 2007 Apr;255(1-2):57-63. https://doi.org/10.1016/j.jns.2007.01.070
- 20 Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):38-43. https://doi.org/10.1136/jnnp.2010.237834
- 21 Nygaard GO, Celius EG, Benavent SAR, Sowa P, Gustavsen MW, Fjell AM et al. A longitudinal study of disability, cognition and gray matter atrophy in early multiple sclerosis patients according to evidence of disease activity. PLoS One. 2015 Aug;10(8):e0135974. https://doi.org/10.1371/journal.pone.0135974
- 22 Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C et al. Longitudinal associations between MRI and cognitive changes in very early MS. Mult Scler Relat Disord. 2016 Jan;5:47-52. https://doi.org/10.1016/j.msard.2015.10.010
- 23 Hankomäki E, Multanen J, Kinnunen E, Hämäläinen P. The progress of cognitive decline in newly diagnosed MS patients. Acta Neurol Scand. 2014 Mar;129(3):184-91. https://doi.org/10.1111/ane.12161
- 24 Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80. https://doi.org/10.1136/jnnp.70.6.773
- 25 Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):878-85. https://doi.org/10.1136/jnnp.74.7.878
- 26 Pereira AG. Evolução das funções cognitivas psíquicas e motoras dos pacientes portadores de esclerose múltipla [tese]. Porto Alegre: Pontifícia Universidade Católica do Rio Grande do Sul; 2013.
- 27 Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK et al.; MAGNIMS Study Group. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015 Mar;14(3):302-17. https://doi.org/10.1016/S1474-4422(14)70250-9
- 28 López-Góngora M, Querol L, Escartín A. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurol. 2015 Mar;15:40. https://doi.org/10.1186/s12883-015-0296-2
- 29 Amato MP, Portaccio E, Goretti B, Zipoli V, Iudice A, Della Pina D et al.; TuSCIMS Study Group. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler. 2010 Dec;16(12):1474-82. https://doi.org/10.1177/1352458510380089